IBM leads on AI healthcare patent quantity while Philips is ahead on quality, data analysis shows
Life sciences companies are being left to play catch-up as tech companies build robust portfolios in anticipation of a market whose time is about to come
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.